First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases

HONG KONG, Feb 10, 2023 – (ACN Newswire) – Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that the first patient in the United States (US) was dosed in a global multi-centre phase 3 clinical trial (NCT04740671) of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody injection jointly developed by the Group and Shanghai Henlius Biotech, Inc. ("Henlius", Stock Code: 2696.HK), for the treatment of wet age-related macular degeneration (wAMD). Previously, the first patients in the European Union (EU) and Australia were dosed in the same global multicenter phase 3 clinical trial of EB12-20145P (HLX04-O). Meanwhile, the first patient has been dosed in a parallel phase 3 clinical trial in China for EB12-20145P (HLX04-O) for the treatment of wAMD.

This randomised, double-blinded, active-controlled, global phase 3 study aims to compare the efficacy and safety of EB12-20145P (HLX04-O) with ranibizumab in patients with wet age-related macular degeneration (wAMD). Eligible patients will be randomised 1:1 to receive intravitreal injection of EB12-20145P (HLX04-O) (1.25 mg) or ranibizumab (0.5 mg) every 4 weeks for 48 weeks. The primary objective is to compare the efficacy of EB12-20145P (HLX04-O) with ranibizumab at Week 36 in patient's study eye with wAMD. The primary endpoint is the mean change from baseline in the best-corrected visual acuity (BCVA) at Week 36. Secondary objectives include the evaluation of other efficacy endpoints, safety, tolerability, and pharmacokinetic profiles.

EB12-20145P (HLX04-O) is a recombinant anti-VEGF humanized monoclonal antibody injection constructed using genetic engineering technology independently developed by Henlius. EB12-20145P (HLX04-O) can inhibit VEGF's binding to its receptor Flt-1 (VEGFR-1) and KDR(VEGFR-2) on endothelial cells to inhibit the activation of its tyrosine kinase signalling pathway, inhibit endothelial cell proliferation and reduce angiogenesis, thereby treating eye diseases associated with angiogenesis. According to the requirements of ophthalmic drugs, the Company has developed EB12-20145P (HLX04-O) which optimizes the prescription, specifications, and production processes of HANBEITAI, assuming that the active ingredients remain unchanged. Through a series of comparability analysis, it is proved that the changes in the production process and prescription of the preparation have no adverse impact on the quality, safety and efficacy of the preparation.

In addition to the EU and Australia, the clinical trial applications of EB12-20145P (HLX04-O) had been approved in Singapore and other countries and regions. Essex and Henlius will jointly manage progressively the global multi-centre clinical trials of EB12-20145P (HLX04-O) and apply marketing authorization in China, Australia, the EU, and the US around the globe based on the research results. EB12-20145P (HLX04-O) has the potential to be one of the first bevacizumab approved for use in ophthalmic diseases, benefiting more patients with eye diseases worldwide.

About wet age-related macular degeneration (wAMD)
Age-related macular degeneration (AMD) is one of the leading causes of visual impairment and blindness in the elderly worldwide [1]. According to the World Health Organization (WHO), about 30 million people have suffered from AMD globally, and about half a million people become blind due to AMD each year [2]. Wet age-related macular degeneration (wAMD) is characterized by the formation of subretinal choroidal neovascularization (CNV) and is responsible for approximately 90% of cases of AMD-related blindness. Due to an aging population, wAMD has become a serious social medical problem and indicated a huge burden of unmet need [3]. With the development of treatment for fundus diseases, anti-VEGF drugs are becoming the first-line therapy for the management of wAMD [4], with the efficacy and safety of vitreous injection of bevacizumab for wAMD verified in multiple clinical studies[5-11].

About Essex
Essex Bio-Technology Limited is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic b-bFGF (FGF-2), having six commercialised biologics marketed in China since 1998. Additionally, it has a portfolio of commercialised products of preservative-free unit-dose eye drops and Shilishun (Iodized Lecithin Capsules) etc.. The products of the Company are principally prescribed for the treatment of wounds healing and diseases in Ophthalmology and Dermatology, which are marketed and sold through approximately 10,710 hospitals and managed directly by its 43 regional sales offices in China. Leveraging on its in-house R&D platform in growth factor and antibody, the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields and indications.

Reference
[1] Ouyang Lingyi, Xing Yiqiao. Advances in the use of anti-VEGF drugs in wet age-related macular degeneration [J]. International Eye Science, IES,2020(1).
[2] Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004 Nov;82(11):844-51.
[3] Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2): e106-116.
[4] Li X R, Liu J P. Recognition of anti-VEGF therapy base on the mechanism of VEGF in wet age-related macular degeneration[J]. Zhonghua Shiyan Yanke Zazhi/Chinese Journal of Experimental Ophthalmology, 2012, 30(4):289-292.
[5] Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, Johnston R, Bunce C, Xing W; ABC Trial Investigators. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multi-centre randomized double masked study. BMJ. 2010 Jun 9;340:c2459.
[6] Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011 May 19;364(20):1897-908.
[7] Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology. 2012 Jul;119(7):1399-411.
[8] Kodjikian L, Souied EH, Mimoun G, Mauget-Faysse M, Behar -Cohen F, Decullier E, Huot L, Aulagner G; GEFAL Study Group. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Ophthalmology. 2013 Nov;120(11):2300-9.
[9] Krebs I, Schmetterer L, Boltz A, Told R, Vecsei-Marlovits V, Egger S, Schonherr U, Haas A, Ansari-Shahrezaei S, Binder S; MANTA Research Group. A randomized double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. Br J Ophthalmol. 2013 Mar;97(3):266-71.
[10] Berg K, Pedersen TR, Sandvik L, Bragadottir R. Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. Ophthalmology. 2015 Jan;122(1):146-52.
[11] Schauwvlieghe AM, Dijkman G, Hooymans JM, Verbraak FD, Hoyng CB, Dijkgraaf MG, Peto T, Vingerling JR, Schlingemann RO. Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study. PLoS One. 2016 May 20;11(5): e0153052.

Media Enquiry:
Strategic Financial Relations Limited (Website: http://www.sprg.com.hk)

Shelly Cheng +852 2864 4857 shelly.cheng@sprg.com.hk
Yan Li +852 2114 4320 yan.li@sprg.com.hk
June Tuo +852 2864 4848 june.tuo@sprg.com.hk
Angela Shen +852 2864 4870 angela.shen@sprg.com.hk
Media: media@essex.com.cn

Investor Enquiry:
Investor Relations: investors@essex.com.cn

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific

SYDNEY, AU, Feb 10, 2023 – (ACN Newswire) – Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phase 1 trial activity including current metrics on fast growth regions and therapeutic areas. The data analysis found that Asia Pacific has been the fastest-growing region for Phase 1 trials in the last ten years, reaching a share of 58% in 2022, with China leading the Phase I trials globally.

According to the report, titled "Phase I Global Clinical Trial Landscape – Focus on Asia Pacific", in 2022 Asia Pacific accounted for a 58% share of the approximately 3,600 Phase I trials initiated globally in 2022. The report found that Asia Pacific has been the fastest growing region for Phase 1 trials in the last ten years with a 10Y CAGR of 18%. Between 2018 and 2022, the region has had consistent performance and has been maintaining its majority share since 2018, with a peak of 61% share achieved in the year 2021. Mainland China, Australia, South Korea, Japan and India were the top five Asian locations, and together contribute over 50% of the global phase I trials.

One of the key reasons why Asia Pacific is in demand is that it has the shortest patient enrolment duration and fastest recruitment rate. Asia Pacific region has a much wider patient base which expedites the patient time recruitment process and shortens the trial duration enabling initiation and completion of trials.

The report found that Asia Pacific also leads phase I trials across the top therapeutic areas. Oncology, infectious disease, CNS, cardiovascular and metabolic disorders are the top therapeutic areas of Phase I trials across the top Asian locations of China, Australia, South Korea, Japan and India. Of all the five locations put together, China occupies the major share (>80%) of phase I trials in all the top therapeutic areas considered together.

View "Phase I Global Clinical Trial Landscape – Focus on Asia Pacific", the new report, on this link: https://tinyurl.com/novotech-global-report

See the report for Phase 1 location and therapeutic area analysis including:
– IMMUNOMODULATORY THERAPY
– IMMUNO-ONCOLOGY
– ADOPTIVE CELL THERAPY
– ALLOGENIC, AUTOLOGOUS, STEM CELL AND REGENERATIVE MEDICINE
– DNA AND RNA
– VACCINES
– MULTI-SPECIFIC MONOCLONAL ANTIBODY
– MICROBIOME

Cell & Gene

The latest data also shows Asia Pacific is the fastest-growing region globally for cell & gene therapy trials representing more than a third of all cell & gene studies, with China leading in the region. The region already accounts for over a third of cell & gene therapy trial activity and shows a nearly 50% faster growth rate in cell & gene therapy trials compared to ROW between 2016 and 2021. China shows a 15% faster growth rate than the ROW. After oncology, the majority of cell & gene trials are in infectious diseases, CNS, and cardiovascular diseases. In addition, the Asia Pacific is the leading location globally for CAR-T trials with China attracting ~60% of all CAR-T trials globally between 2015-2022.

European expansion – global footprint

Novotech offers a unique and unparalleled suite of early to late-phase CRO services across Europe and the US, with a specialist focus on Asia Pacific where the company has built a reputation for delivering high-quality expedited clinical trials. Novotech recently acquired EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech's global expansion program in Europe and the US.

Award recognition

Novotech has recently been benchmarked as a top 10 CRO among the world's leading CROs, has been awarded the Asia-Pacific Cell & Gene Therapy Clinical Trials Excellence award and selected for the Asia-Pacific Contract Research Organization Company of the Year Award. The company has signed 45 Leading Site Partnership agreements over the last 3 years.

View "Phase I Global Clinical Trial Landscape – Focus on Asia Pacific", the new report, on this link: https://tinyurl.com/novotech-global-report

About Novotech (Novotech-CRO.com)

Novotech is internationally recognized as the leading Asia Pacific centred biotech Contract Research Organization (CRO) with global execution capabilities. Novotech is a clinical CRO with labs, phase I facilities, drug development consulting services and FDA regulatory expertise and has experience in over 3,700 pre-clinical and clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biotech clients conducting clinical trials in Asia Pacific, the US and Europe. Novotech has over 2700 staff working across offices in 20 geographies. For more information visit https://novotech-cro.com/contact

Media Contact
David James
E: communications@novotech-cro.com
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

XOX Strengthens Presence in Local Football Scene with KLCFC Partnership

KUALA LUMPUR, Feb 10, 2023 – (ACN Newswire) – XOX Berhad (XOX), via its sports marketing arm, XOX Pro Sport Sdn. Bhd., and the Kuala Lumpur City Football Club (KLCFC) have kick-started a partnership to offer XOX's comprehensive range of product and service to the public. The companies in XOX's ecosystem range from technology offerings to financial products, events management and even apparels.

Mr Winson Wong, Chief Operating Officer XOX; Mr. Ng Kok Heng, Group CEO XOX; Mr. Stanley Bernard, CEO of Kuala Lumpur City FC; Mr. Noor Azri bin Noor Azerai, Director of Rinani Group Berhad [L-R]

Mr. Tan Tai Liang, Chief Sales Officer; Ms. Sylvia Kong Choo Hui, Group Chief Financial Officer XOX; Mr. Yakub Hussaini, General Manager Kuala Lumpur City FC; Mr. Winson Wong, Chief Operating Officer XOX; Mr. Ng Kok Heng, Group CEO XOX, Mr. Stanley Bernard, Chief Executive Officer Kuala Lumpur, Mr. Noor Azri Bin Noor Azerai, Director of Rinani Group Berhad [L-R]

The initial collaborative products to be rolled out are multiple co-branded mobile plans by another of XOX's subsidiary, ONEXOX Sdn Bhd, which are targeted at KLCFC's avid supporters. Fans of the football club who subscribe to the XOX mobile service will have the opportunity to receive exclusive news, content, multimedia updates, and promotions, among other exciting offers, which will be available in stages.

Mr. Stanley Bernard, Chief Executive Officer of KLCFC, said, "The club is undergoing a makeover and is currently prioritising its commercial side. With a growing fanbase of over 200,000 individuals garnered over the years, the club plans to leverage on this advantage to ensure its business sustainability in the long run."

"XOX will open its suite of products and services for KLCFC to collaborate and partner with, including but not exclusive to, continuous social media content, automated vending machines, merchandising, royalty programmes and fintech services," said Mr. Ng Kok Heng, Group Chief Executive Officer of XOX.

"Being affiliated with Perak FC, and now KLCFC, XOX has expanded its reach into an urban fanbase with 100 percent fans' growth, as well as corporate entities who are also involved with the sport," he added.

Through XOX's wholly owned subsidiary, Perak FC, a similar commercial model is underway, with some degree of success, as it replicates the company's initial strategy.

In the competitive world of telecommunications, quality content is key to marketing and customer retention. XOX has supported Malaysian sports throughout the years and will now focus on developing content and exposure for grassroot football.

XOX Berhad: 0165 [BURSA: XOX], https://xox.com.my/

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Bintai Kinden Wins RM14.2 Million Project from TNB

PETALING JAYA, Malaysia, Feb 10, 2023 – (ACN Newswire) – Bintai Kinden Corporation Bhd (Bursa: BINTAI, 6998), a mechanical and electrical (M&E) engineering services specialist, is pleased to announce that the Company's wholly-owned subsidiary, Kejuruteraan Bintai Kindenko Sdn Bhd (KBK), has been awarded a project worth RM14.2 million by Tenaga Nasional Berhad (TNB) for the installation of two 132kV transformer bays air insulated switchgear complete with the relevant primary, secondary, cables and all associated civil works located in Pasir Besar, Negeri Sembilan.

Executive Director of Bintai Kinden, En. Azri Azerai

The project's scope of work also includes a 33kV building, two 300kVA 33/0.415kV local transformers, 33kV GIS single busbar (eight outgoing, two incomer, two local transformers and two bus-ties), 33kV CRP, 33kV RTU, 33kV SIP and 33kV MPE, neutral earthing system, earthing system extension, lightning protection system, associated secondary works (protection & telecontrol) and, associated underground cable works for power transformer, local transformer and bus-tie.

KBK, a specialist in M&E engineering services, was also awarded a project worth RM39.0 million by TNB for the installation of a 132kV underground cable double circuit in late November 2022.

Azri Azerai, Executive Director of Bintai Kinden said, "We are happy to work with TNB as both parties have a working relationship and track record going back some years. The award of the contract is also testament to our expertise and experience in M&E engineering services including design, installation and commissioning.

"Bintai Kinden has in recent years been growing our range of expertise through investments and acquisitions that leverage on our strengths and market network. The Company has mid-to-long-term plans to transform to a multidisciplinary M&E engineering services specialist that also include strategic partnerships like the one we recently inked with Sarawak Consolidated Industries Berhad."

Past TNB projects in which Bintai Kinden has been involved in include the 132kV Kuchai Lama switching station, 132kV MRT Bukit Serdang switching station, 132kV single-circuit underground cable from PMU Galloway to PMU KLCC2 and, 132kV bulk supply connection to KTMB Sentul feeder station. Total unbilled order book under M&E segment of Bintai Kinden is RM143.41 million.

Bintai Kinden Corporation Berhad: 6998 [BURSA: BKC], http://bintai.com.my/

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Infocus International Brings Back Renewable Energy Project Finance & Financial Modelling Masterclass

Singapore, Feb 10, 2023 – (ACN Newswire) – Infocus International Group is bringing back the Renewable Energy Project Finance & Financial Modelling online masterclass and it will be commencing live on the 7th March 2023.

The objective of this course is to provide participants with an enhanced understanding of the financial modelling and key documentation requirements of all interested parties to today's RE PF transactions. This programme provides you with proven PF modelling techniques and transaction management techniques which will enable you to quantitatively assess risks, resolve constraints, and reach project financial closure. The practical models for wind, solar, hydro, biomass, and geothermal PF models will be demonstrated through a series of real case examples of projects and transactions from Southeast Asia, South Asia, the Middle East, Europe, and North America.

A past participant from Ib Vogt shared that, "The trainer has in-depth knowledge in the subject. This discussion is very good especially most participants are seasoned players with the industry."

Another past participant from Electricity Generating Authority of Thailand mentioned that, "This course is not only recommended to the ones with experience in this field, but also for people with no or less experience. Everyone will definitely gain knowledge and be able to apply it during the course."

Benefits of Attending:
– Identify key requirements of limited-recourse Project Finance for Renewable Energy transactions, Power Purchase Agreements (PPAs) & PF documentation management
– Review solar, wind, hydro, biomass & geothermal PF financial model design requirements, presentation & formatting standards
– Program financial statements, cash flows, profit & loss statements and managing international accounting standards for RE PF transactions
– Project RE PF balance sheets, SPV reserve accounts, PF refinancing, and conducting sensitivity analyses
– Oversee the design and review of RE PF financial models based upon your own company's risk profile and corporate goals
– Apply clear investment incentives and renewable energy credit (REC), feed-in-tariffs (FIT), and credit enhancements for bankable private investments in RE generation
– Manage and oversee successful renewable power project finance transactions

Join us now to know more about the techniques & models for bankable green energy transactions of solar, wind, hydro, biomass & geothermal power investments in today's competitive energy markets.

Want to learn more?
Simply email to esther@infocusevent.com or call +65 6325 0210 to obtain your FREE COPY of event brochure. For more information, please visit www.infocusinternational.com/renewable-project-finance

About Infocus International Group

Infocus International is a global business intelligence provider of strategic information and professional services for diverse business communities. We recognises clients' needs and responds with innovative and result oriented programmes. All products are founded on high value content in diverse subject areas, and the highest level of quality is ensured through intensive and in-depth market research from local and international insights. For more information: www.infocusinternational.com

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Hong Kong’s Middle East mission lays groundwork for new business opportunities

HONG KONG, Feb 10, 2023 – (ACN Newswire) – Since the recent reopening of the Hong Kong-mainland border, the Hong Kong Trade Development Council (HKTDC) embarked on a week-long business mission to the Middle East, led by Mr John Lee, Chief Executive of the Hong Kong Special Administrative Region (HKSAR).

The Hong Kong business delegation signed 13 MoUs during this trip. In this photo, HKTDC and Abu Dhabi Chamber of Commerce and Industry signed an MoUs at the Abu Dhabi-Hong Kong Business Forum on 7 February.

The Hong Kong delegation engaged with senior representatives of government, local Chambers of Commerce and key corporations via business meetings and seminars. In this photo, they are on a company visit to SABIC, the leading petrochemicals manufacturer in the Middle East.

Led by Mr John Lee, HKSAR Chief Executive, the delegation visited various companies in Saudi Arabia and the UAE to learn about the latest developments. Here, the group visit THE LINE Experience exhibition (NEOM) showcasing innovative urban designs of the futuristic city NEOM.

Mr Lee was accompanied by principal officials Mr Horace Cheung, Deputy Secretary of Justice; Mr Christopher Hui, Secretary for Financial Services and Treasury; and Mr Algernon Yau, Secretary for Commerce and Economic Development.

The signing of 13 Memoranda of Understanding (MoU) during the mission signals new collaboration opportunities between Hong Kong and Middle East companies and organisations in business, finance, innovation and technology, sustainability and transport.

Over 30 business leaders from finance, logistics, technology and professional services joined the mission to Riyadh, Abu Dhabi and Dubai.

By showcasing Hong Kong's strengths through business and official exchanges and proactive publicity, the mission deepened economic and trade relations and enhanced cultural exchange between Hong Kong and Saudi Arabia and the United Arab Emirates (UAE), helping Hong Kong attract investment and talent. It also solidified Hong Kong's role as the global gateway to Mainland China and a leading business and investment hub in Asia.

The Hong Kong delegation met with senior representatives of government, local Chambers of Commerce, including the Saudi Chinese Business Council, Abu Dhabi Chamber of Commerce & Industry, Invest in Sharjah and Dubai Chambers, the last of which also announced the establishment of a Hong Kong office yesterday.

HKTDC Chairman Dr Peter K N Lam said, "The Middle East has an important role to play in driving the global economy and has important strategic significance in supporting the development of the Belt and Road. As Hong Kong reopens to the world, we have lost no time in organising this Hong Kong business delegation to the Middle East, led by the Chief Executive and three principal officials. Apart from presenting Hong Kong's latest incentives and policies to attract investment and talent, we also introduced new opportunities arising from the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) and encouraged UAE and Saudi companies to take advantage of Hong Kong's investment and business platforms."

Dr Lam added, "From our meetings and visits, we saw that Saudi Arabia and the UAE welcome deeper and broader ties with Hong Kong to support their strategic development. I am delighted that many MoUs have been signed across many sectors. These will lay a solid foundation for future long-term cooperation. With our 50 offices around the world, the HKTDC will continue to help businesses open doors and to promote Hong Kong as a global business hub."

Apart from over 30 international trade fairs and conferences in Hong Kong, the HKTDC organises large-scale overseas mega promotions, such as Think Business, Think Hong Kong, which will be held in Thailand in July to promote the Hong Kong brand together with the Hong Kong family of organisations.

The MoUs signed during this mission include:

1. Hong Kong Exchanges and Clearing Limited (HKEX) and Saudi Tadawul Group Holding Company
2. SenseTime and King Abdullah Financial District (KAFD) (Letter of Intent)
3. Hong Kong General Chamber of Commerce (HKGCC) and Riyadh Chamber
4. Templewater Ltd, Bravo Transport Services Ltd and Wisdom Motors (Hong Kong) Ltd and Nesma Holding Ltd
5. SenseTime and Sela Company (Letter of Intent)
6. Hutchison and King Salman Energy Park (SPARK)
7. HKTDC and Dubai Chamber
8. Ho & Partners Architects, Negawatt, Masdar City, and The Catalyst
9. HKSTP and Sharjah Research Technology & Innovation Park
10. Hong Kong Cyberport and Dubai Future Foundation
11. HKTDC and Invest in Sharjah
12. HKTDC and Abu Dhabi Chamber of Commerce & Industry
13. Federation of Hong Kong Industries (FHKI) and Abu Dhabi Chamber of Commerce & Industry

Photo Download: https://bit.ly/3DY0O2i

About HKTDC

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn

Media enquiries
Please contact the HKTDC's Communications and Public Affairs Department:
Sunny Ng, Tel: +852 2584 4357, Email: sunny.sl.ng@hktdc.org
Sam Ho, Tel: +852 2584 4569, Email: sam.sy.ho@hktdc.org

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Former Singapore Parliamentarian’s Swiss Digital Assets Company Receives Regulatory Approval

Calvin Cheng’s Damoon Technologies has obtained membership status from the Swiss Financial Services Standard Association (‘VQF’), which is officially recognised by the Federal Financial Market Supervisory Authority (‘FINMA’)
This comes on the back of Cheng’s Web3 Company obtaining the Virtual Asset License from the Dubai Virtual Asset Regulatory Authority (VARA)
Damoon will offer crypto-fiat-crypto payment services, as well as a digital assets custodian

ZURICH, SWITZERLAND, Feb 10, 2023 – (ACN Newswire) – Singapore investor and former parliamentarian Calvin Cheng’s Swiss company, Damoon Technologies (‘Damoon’) has been granted membership in the Swiss VQF, joining the ranks of some of the world’s leading digital assets businesses.

The latest development officially opens the door for Damoon to establish a presence in Switzerland. Thedigital assets company is building a platform for users to engage in crypto- to-fiat payments and vice versa, as well as a digital assets custody service.

VQF is the largest and oldest cross-industry Self-Regulatory Organisation (SRO) in the country and is officially recognised by FINMA, Switzerland’s financial services watchdog.

Damoon must now comply with Swiss anti-money laundering (AML) regulations. Thanks to this, the company is in a unique position to work with demanding clients and offer them a place that provides efficiency, security and regulatory clarity.

Calvin Cheng commented, “I believe in the future of digital assets, but this has to be done in accordance with traditional finance’s compliance standards. Switzerland is the pre- eminent global financial hub, and is the ideal place to base crypto-fiat-crypto financial services, as well as a trusted custodian.”

Recently, Damoon has also joined the Crypto Valley Association in Zug. “Crypto Valley Association are excited to welcome Damoon Technology and Mr. Calvin Cheng as members,” said a spokesperson for the organization.

Currently, Damoon is in the process of building its compliance and operational team in Zurich and Zug, Switzerland. The company expects to start operations by the end of Q2 2023.

Earlier in 2022, Cheng’s Web3 Holdings FZE was awarded the coveted provisional Virtual Asset License by VARA in Dubai, United Arab Emirates. The license granted similarly promotes greater customer assurance and risk protection.

About Calvin Cheng

Calvin Cheng is currently the Chairman of Australia Stock Exchange (ASX) listed EdTech firm ReTechTechnology Co, which he led to an Initial Public Offering, together with leading investors from China.ReTech’s shareholders include several co-founders of Alibaba, as well as founders of other leading Chinese tech companies.

Cheng was a former appointed Member of Singapore’s Parliament and a Young Global Leader of the World Economic Forum. He is also the Republic of Serbia’s first Honorary Consul to the Republic of Singapore.

For media inquiries and interview requests, please contact:
Tang Hong Ee (Financial PR) (T) 6438-2990
(E) hongee@financialpr.com.sg

FBS Celebrates Its 14th Birthday, Inviting Traders to Join Their Big Promo Event

New York, NY, Feb 9, 2023 – (ACN Newswire) – FBS, a licensed world Forex broker, is excited to invite its traders to join in the celebration of its 14th birthday with the FBS Ultimate Trading Birthday promo. The event offers the chance to win big prizes, including the grand prize of a luxury car.

Open to all traders

FBS, a world-trusted fintech company, turns 14 this year. To celebrate another great year, the broker is running the FBS Ultimate Trading Birthday promotion, turning the event into a true traders’ party. Whether users are a new trader or an FBS Partner, a scalper or a swing trader, everyone is welcome to join the celebration.

The promo is available in the FBS Personal Area app and desktop version, or the FBS Trader app.

FBS Ultimate Trading Birthday will run from February 9 to March 9 to ensure that every trader of the FBS diverse and large trading community has enough time to get their reward.

Earning guaranteed rewards

FBS is making sure that no one leaves the celebration empty-handed. To get the guaranteed prize, a trader needs to collect five trading tickets, one per traded lot. Once five trading tickets are gathered, traders can choose from a variety of prizes, including cash rewards, VIP analytics, or one-on-one consultation with FBS financial analysts.

FBS Ultimate Trading Birthday can offer even more. Each of the collected tickets is a chance to win bigger rewards.

Raffle prizes for everyone

In addition to the guaranteed rewards, participants will also have the chance to win amazing prizes in the raffle. The grand prize is a LA-Class car, but there are also other valuable prizes up for grabs, including a MacBook Air 13, iPad Pro 11, and various smartphones and laptops.

The raffle winners will be randomly selected and announced on March 17, 2023, at 13:00 GMT+2. The results will be posted on the FBS website.

Don’t miss out on the chance to celebrate FBS 14th birthday and win big with FBS Ultimate Trading Birthday.

About FBS

FBS is an international brand present in over 150 countries. Independent companies united by the FBS brand are devoted to their clients and offer them opportunities to trade Margin FX and ᏟᖴᎠs.

FBS Markets Inc. – license IFSC/000102/310
Tradestone Ltd. – CySEC license number 331/17, FCA temporary permit 808276
Intelligent Financial Markets Pty Ltd – ASIC Licence number 426359

Social Links
Facebook: https://www.facebook.com/financefreedomsuccess
YouTube: https://www.youtube.com/user/FBSforex
Instagram: https://www.instagram.com/FBS_forex/
Telegram: https://t.me/fbsanalytics

Media Contact
Media team, FBS
Email: support@fbs.com
Website: https://fbs.com/

SOURCE: FBS

Rare Artworks by Picasso and UAE Royal Family Member to be Auctioned together for the First Time

DUBAI, Feb 9, 2023 – (ACN Newswire) – The Rare Antiquities is revolutionising the way museums and galleries are presented in the web 3.0 space through their unique technology. By making high-value art available to everyone, regardless of the budget. It is the first platform to fractionalise a Banksy and distribute the fractionalised pieces as individual NFTs, customisable in size. They have live fractionalised auctions scheduled throughout 2023 for art and antiquities valued at over $1Bn.

To start off the year The Rare Antiquities will host one of their first auctions on the 12th of February 2023. The Red carpet event will take place in Sama L Ain Gallery in Dubai where three Picassos and one painting created by one of the members of the Ras Al Khaimah Royal Family will be auctioned for shared ownership. The main aim of the event is to allow the appreciation of art to rise through shared ownership by giving more people the opportunity to own a piece of it.

The painting that will be featured in the auction was created by Artist Noora Alredhwan, the Mother of Sheikh Humaid Bin Khalid Al Qasimi. It is dedicated to the 50 year anniversary of the UAE. During EXPO 2020 Dubai it was displayed in the UAE Pavilion for six months. Now, for the first time, it will be accessible for the public.

One of the paintings on auction features a lithography that Pablo Picasso created a few years after the end of the second world war, in 1949. Picasso was particularly passionate about this technique, where stone or metal are treated in a way so that it can be painted or printed on. Another one of the Picasso paintings was created in 1945, using the gouache technique with opaque watercolor, ink and wash on paper. One of Picasso's later works, "Like an animal", which was created in 1957 will also be part of the auction.

Ryan Howells, Founder of The Rare Antiquities, commented on the project and explains the motivation behind it: "The fractionalisaton of art represents a new paradigm fostering a new approach to the appreciation of art. Through this event we hope to bring together like minded people where they can enjoy what each art piece has to offer."

One of the hosts of this special event is Sheikh Humaid Bin Khalid Al Qasimi. This auction is not just about the art, it's about bringing to market a new way of sharing ownership of artwork that at any other time would be inaccessible to the majority of people.

"For us, art is an important channel to connect with society. It is about accessibility: One aspect of this initiative is that sharing our own artwork with the people brings us closer to the public. Another aspect is that technology enables shared ownership, which allows for more people to access this art," said Sheikh Humaid Bin Khalid Al Qasimi.

Mohamed Al Banna, initiator and mentor of the the initiative said: "The collaboration with The Rare Antiquities follows our mission of building bridges: On the one hand we're building a bridge between Royal families and the people through art, and on the other hand we create access to highly curated art, like the Picasso works, for a larger audience and not just a few privileged people."

The Rare Antiquities brings museums and galleries to the Metaverse with Rare City which also hosts districts for education, charity, crowdfunding and more. AURA Skypool Lounge, the world's highest 360 degree infinity pool, will now be made available to everyone through a digital space created in the Metaverse.

The move into the Metaverse for the destination is being curated by Rare City which is a part of The Rare Antiquities that leverages blockchain technology for the Rare City Metaverse. This is the first of many venues 'The Rare City' plans to bring into the Metaverse, allowing people to relive a memory, experience or a unique adventure from anywhere.

About The Rare Age

The Rare Age brings museums and galleries to web 3.0 through our one-of-kind technology making high valued art accessible to any individual regardless of budget. The first platform to automate fractionalisation of a Banksy and distribute fractions as individual, configurable in size, NFTs.

Live fractionalised auctions scheduled throughout 2023 for art and antiquities valued at over $1 billion. The Rare Age brings museums and galleries to the Metaverse with The Rare City which also hosts districts for education, charity, crowdfunding and more.

https://therareantiquities.com/

For more information contact:
Faisal Zaidi
Inacta Communications
faisal.zaidi@inacta.com
media@inacta.com
+971552000840

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Hong Kong and UAE explore collaboration opportunities

DUBAI, Feb 9, 2023 – (ACN Newswire) – A delegation of business leaders from the Hong Kong Special Administrative Region (HKSAR), led by the city's Chief Executive and principal officials and organised by the Hong Kong Trade Development Council (HKTDC), is in the United Arab Emirates (UAE) this week to strengthen existing business ties and develop new areas of collaboration in technology, sustainability and smart city development, in addition to traditional sectors of finance and trade.

A Memorandum of Understanding (MoU) has been signed between HKTDC and Dubai Chambers.

Panel speakers discussed the opportunities for deeper UAE-Hong Kong collaboration at the business forum before a dinner for the Dubai and Hong Kong business communities.

With Hong Kong's unrivalled access to China and Asia and the UAE's role as a gateway to the Gulf Cooperation Council (GCC) and European markets, the relationship between the two commercial centres is already providing important benefits to a range of businesses.

The arrival of the high-level business delegation, which comprises senior executives from Hong Kong's financial institutions, financial regulators as well as major players in innovation and technology (I&T), sustainability and smart city solutions, will help accelerate the commercial ties between the HKSAR and the Emirates, and support the strategic development of the UAE, Hong Kong and mainland China.

The important strategic relationships, which exist between China and the UAE, are based on a shared backing for liberal trade policies, investment in cutting-edge technology, low tax regimes and backing for pro-business regulation.

A press conference was held on 8 February in Dubai, followed by a business forum and dinner in the presence of H.E. Dr Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade, H.E. Mr Abdul-Aziz Abdulla Al Ghurair, Chairman of Dubai Chambers and H.E. Sultan Bin Sulayem, Chairman of Dubai International Chambers.

Hong Kong's Chief Executive Mr John Lee said: "The UAE is Hong Kong's largest trading partner in the Middle East region. We treasure this long-standing relationship, and I believe that we can now take it to a higher level. That's why I'm here, together with these business leaders from Hong Kong – some 30 strong – to tell you that our business and investment doors are wide open and welcoming for UAE companies and investors. For a world of opportunities."

"The commercial and political ties between Hong Kong and the UAE are growing ever stronger. It is clear we both approach business in the same way, backing innovation, investing in technology and looking for sustainable solutions. This business mission to the UAE shows the depth of existing commercial relationships and the potential to do a lot more."

In response, H.E. Dr Thani bin Ahmed Al-Zeyoudi stressed the strength and durability of the strategic relations between the United Arab Emirates and the People's Republic of China, which are witnessing continuous development, especially in the areas of economics and trade. The forward-looking and visionary leadership of the two countries is building a strong partnership, opening up new opportunities and broadening bilateral economic cooperation.

His Excellency added: "Strengthening investment and trade partnerships with Hong Kong supports the strategic cooperation between the UAE and China and contributes to opening new business fields, stimulating communication between the Emirati-Chinese business communities, especially in light of new economic opportunities".

His Excellency continued: "The value of foreign trade between the UAE and Hong Kong amounted to about AED32 billion (US$8.7 billion) during the first 9 months of 2022, achieving a growth of 36% compared to the same period in 2021, while Hong Kong was among the top 10 trading partners for the UAE during 2021, with a contribution of more than 2% of the UAE's total non-oil trade."

His Excellency indicated that the forum represents an important step in supporting increased trade and enhancing prospects for bilateral cooperation in a wide range of sectors, especially shipping, logistics, the service sector and air transport. It maximises benefits for Emirati companies and their counterparts in Hong Kong.

HKTDC Chairman Dr Peter K N Lam mentioned in his opening remarks that "Dubai and Hong Kong are natural partners, when it comes to creating business opportunities. The signing of three MoUs* at our event tonight shows the tremendous potential for deeper collaboration. Creating business opportunities has been the work of the Hong Kong Trade Development Council for over 55 years, and I am pleased to be part of these exciting times."

Representing the business community in Dubai, H.E. Abdul-Aziz Abdulla Al Ghurair, Chairman of Dubai Chambers, commented: "I am proud to say that the UAE is the largest trading partner for Hong Kong in the Middle East. Non-oil trade between the UAE and Hong Kong reached AED22.2 billion in the first half of 2022, registering 16.2% growth compared to the first half of 2021. With the presence of our new international office in Hong Kong, I look forward to seeing continued collaboration with our Hong Kong counterparts and seeing the relationship between our countries thrive and prosper even more."

In the trade delegation, Chief Executive Mr Lee is joined by three principal officials: Deputy Secretary of Justice Mr Horace Cheung, Secretary for Financial Services and Treasury Mr Christopher Hui and Secretary for Commerce and Economic Development Mr Algernon Yau.

Other business leaders from Hong Kong and the Emirates also exchanged views at a panel discussion yesterday. Chaired by Mr Yau, panel speakers included Mr Nicolas Aguzin, Chief Executive Officer of Hong Kong Exchanges and Clearing Ltd, Dr Sunny Chai, Chairman of the Federation of Hong Kong Industries and Chairman of the Hong Kong Science & Technology Parks Corporation (HKSTP), Mr Horace Cheung, and H.E. Hussain Al Mahmoudi, Chief Executive Officer of Sharjah Research Technology & Innovation Park (SRTIP) and H.E. Faisal Juma Khalfan Belhoul, Vice Chairman of Dubai International Chamber.

* 3 MOUs have been signed between:
– HKTDC and Dubai Chamber
– Ho & Partners Architects, Negawatt, Masdar City, and The Catalyst
– HKSTP and Sharjah Research Technology & Innovation Park

Hong Kong: Ready for business

As a two-way platform between China and the world and as one of the world's top financial centres, Hong Kong has been supporting businesses and investors worldwide to tap into the vast China and Asia market as well as playing a major role in the global financial system with special connectivity to the China market.

As part of China, but operating under an international system, Hong Kong provides special access to and from the mainland in the flow of capital, goods, technology and people, as defined in the country's national 14th Five-Year Plan. Hong Kong is also a commercial hub for the Belt and Road Initiative, a global development plan initiated by China, and part of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) – an area in Southern China earmarked by the Chinese government as a powerhouse of capital, I&T and cultural exchange driving the country's development.

With the city's common law system, low tax regime, advanced infrastructure and connectivity and a long history as an international trade and business hub, Hong Kong is well-placed to support businesses from all over the world to invest and grow.

Recently, the HKSAR Chief Executive announced in his Policy Address 2022 the wide array of incentives and measures to attract international strategic enterprises and investments to Hong Kong, particularly in areas such as life sciences, health technology, artificial intelligence and data science, financial technology, advanced manufacturing and new energy technology.

Find out more about Hong Kong:

– Hong Kong: general facts https://tinyurl.com/Asias-world-city
– Hong Kong as a global financial centre https://tinyurl.com/Financial-Centre
– Hong Kong's tech and innovation https://tinyurl.com/Tech-Innovation
– Hong Kong as the commercial hub for the Belt and Road Initiative https://tinyurl.com/Belt-and-Road
– Hong Kong as part of the Guangdong-Hong Kong-Macao Greater Bay Area https://tinyurl.com/Greater-Bay-Area
– Photo Download: https://bit.ly/40LxYMu

About HKTDC

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn.

Media enquiries
Credo Communications:
Habib Bacha, Tel: +971 (50) 111 3799, Email: habib.bacha@credocomms.com

HKTDC:
Sunny Ng, Tel: +852 2584 4357, Email: sunny.sl.ng@hktdc.org
Sam Ho, Tel: +852 2584 4569, Email: sam.sy.ho@hktdc.org

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com